The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model

References

• Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V. Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 1986; 6:4650-6; PMID:3025664
   PubMed Web of Science ®Google Scholar
• Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33:357-65; PMID:12567188; https://doi.org/10.1038/ng1093
   PubMed Web of Science ®Google Scholar
• Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 2004; 23:3328-37; PMID:15077186; https://doi.org/10.1038/sj.onc.1207428
   PubMed Web of Science ®Google Scholar
• Siddique M, Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006; 25:3489-500; PMID:16462765; https://doi.org/10.1038/sj.onc.1209405
   PubMed Web of Science ®Google Scholar
• Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 2006; 38:1133-41; PMID:16964264; https://doi.org/10.1038/ng1879
   PubMed Web of Science ®Google Scholar
• Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009; 9:95-107; PMID:19165225; https://doi.org/10.1038/nrc2584
   PubMed Web of Science ®Google Scholar
• Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, Ristimäki A, von Smitten K, Aittomäki K, Heikkilä P, et al. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 2005; 11:5098-103; PMID:16033823; https://doi.org/10.1158/1078-0432.CCR-05-0173
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res 2005; 11:7328-33; PMID:16243804; https://doi.org/10.1158/1078-0432.CCR-05-0507
   PubMed Web of Science ®Google Scholar
• Cattelani S, Ferrari-Amorotti G, Galavotti S, Defferrari R, Tanno B, Cialfi S, Vergalli J, Fragliasso V, Guerzoni C, Manzotti G, et al. The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform. Neoplasia 2012; 14:634-43; PMID:22904680; https://doi.org/10.1593/neo.12594
   PubMed Web of Science ®Google Scholar
• Abdel Hamid TM, El Gammal MM, Eibead GT, Saber MM, Abol Elazm OM. Clinical impact of SNP of P53 genes pathway on the adult AML patients. Hematology 2015; 20:328-35; PMID:25232917; https://doi.org/10.1179/1607845414Y.0000000200
   PubMed Web of Science ®Google Scholar
• Xie X, Jin H, Hu J, Zeng Y, Zhou J, Ouyang S, Yang W, Hu B, Wang H. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Oncol Rep 2014; 31:223-31; PMID:24173110
   PubMed Web of Science ®Google Scholar
• Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C, et al. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 2009; 15:3103-9; PMID:19383811; https://doi.org/10.1158/1078-0432.CCR-08-3120
   PubMed Web of Science ®Google Scholar
• Wang X, Wang YZ, Ma KW, Chen X, Li W. MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Oncol Res Treat 2014; 37:176-80; PMID:24732641
   PubMed Web of Science ®Google Scholar
• Okishiro M, Kim SJ, Tsunashima R, Nakayama T, Shimazu K, Shimomura A, Maruyama N, Tamaki Y, Noguchi S. MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide. Breast Cancer Res Treat 2012; 132:947-53; PMID:21706156; https://doi.org/10.1007/s10549-011-1637-5
   PubMed Web of Science ®Google Scholar
• Maier P, Hartmann L, Wenz F, Herskind C. Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization. Int J Mol Sci 2015; 17:pii: E102
   Web of Science ®Google Scholar
• Hill-Kayser CE, Plastaras JP, Tochner Z, Glatstein E. TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions. Bone Marrow Transplant 2011; 46:475-84; PMID:21113184; https://doi.org/10.1038/bmt.2010.280
   PubMed Web of Science ®Google Scholar
• Deek MP, Benenati B, Kim S, Chen T, Ahmed I, Zou W, Aisner J, Jabbour SK. Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016; 94:147-54; PMID:26700708; https://doi.org/10.1016/j.ijrobp.2015.09.022
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010; 76:S101-7; PMID:20171503; https://doi.org/10.1016/j.ijrobp.2009.05.071
   PubMed Web of Science ®Google Scholar
• Alsner J, Andreassen CN, Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 2008; 18:126-35; PMID:18314067; https://doi.org/10.1016/j.semradonc.2007.10.004
   PubMed Web of Science ®Google Scholar
• Parliament MB, Murray D. Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 2010; 20:232-40; PMID:20832015; https://doi.org/10.1016/j.semradonc.2010.05.003
   PubMed Web of Science ®Google Scholar
• Guo Z, Shu Y, Zhou H, Zhang W, Wang H. Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment. Carcinogenesis 2015; 36:307-17; PMID:25604391; https://doi.org/10.1093/carcin/bgv007
   PubMed Web of Science ®Google Scholar
• Dolgin E. Using DNA, radiation therapy gets personal. Science 2016; 353:1348-9; https://doi.org/10.1126/science.353.6306.1348
   PubMed Web of Science ®Google Scholar
• Zhu F, Dolle ME, Berton TR, Kuiper RV, Capps C, Espejo A, McArthur MJ, Bedford MT, van Steeg H, de Vries A, et al. Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res 2010; 70:5851-9; PMID:20587514
   PubMed Web of Science ®Google Scholar
• Azzam GA, Frank AK, Hollstein M, Murphy ME. Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model. Cell Cycle 2011; 10:1352-5; PMID:21566457; https://doi.org/10.4161/cc.10.9.15344
   PubMed Web of Science ®Google Scholar
• Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, Klein-Szanto A, Hollstein M, Murphy ME. The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol 2011; 31:1201-13; PMID:21245379; https://doi.org/10.1128/MCB.01136-10
   PubMed Web of Science ®Google Scholar
• Roscoe B. Jackson Memorial Laboratory. Green EL. Biology of the laboratory mouse. New York,: Blakiston Division, 1966
   Google Scholar
• Lindsay KJ, Coates PJ, Lorimore SA, Wright EG. The genetic basis of tissue responses to ionizing radiation. Br J Radiol 2007; 80 Spec No 1:S2-6; PMID:17704322; https://doi.org/10.1259/bjr/60507340
   PubMed Web of Science ®Google Scholar
• Wakeland E, Morel L, Achey K, Yui M, Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 1997; 18:472-7; PMID:9357138; https://doi.org/10.1016/S0167-5699(97)01126-2
   PubMedGoogle Scholar
• Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996; 135:1441-55; PMID:8978814; https://doi.org/10.1083/jcb.135.6.1441
   PubMed Web of Science ®Google Scholar
• Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 2012; 920:613-26; PMID:22941631
   PubMedGoogle Scholar
• Deffie A, Wu H, Reinke V, Lozano G. The tumor suppressor p53 regulates its own transcription. Mol Cell Biol 1993; 13:3415-23; PMID:7684498; https://doi.org/10.1128/MCB.13.6.3415
   PubMed Web of Science ®Google Scholar
• Wang S, El-Deiry WS. p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res 2006; 66:6982-9; PMID:16849542
   PubMed Web of Science ®Google Scholar
• Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, Chakravarti A, Clark AG, et al. (1000 Genomes Project Consortium with 843 Collaborators). A global reference for human genetic variation. Nature 2015; 526:68-74; PMID:26432245; https://doi.org/10.1038/nature15393
   PubMed Web of Science ®Google Scholar
• Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 2009; 100:1680-6; PMID:19367277; https://doi.org/10.1038/sj.bjc.6605036
   PubMed Web of Science ®Google Scholar
• Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, et al. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 2006; 97:255-62; PMID:16331344; https://doi.org/10.1007/s10549-005-9119-2
   PubMed Web of Science ®Google Scholar
• Sarkar J, Dominguez E, Li G, Kusewitt DF, Johnson DG. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. Mol Carcinog 2014; 53:648-58; PMID:23475592
   PubMed Web of Science ®Google Scholar